A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug

Archives of Pharmacal Research

Volumn 22, Issue 3, 1999, Pages 279-287

  Lee, Henry J ^a   Ko, Dong Hoon ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Antedrug; Croton oil ear edema; Prednisolone derivative; Receptor binding

Indexed keywords

ANTIINFLAMMATORY AGENT; CARBOXYLIC ACID; CORTICOSTERONE; CROTON OIL; ISOXAZOLE DERIVATIVE; PREDNISOLONE; PRODRUG;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; EAR DISEASE; EDEMA; MALE; ORGAN SIZE; PROTEIN BINDING; RAT; SPRAGUE DAWLEY RAT; SYNTHESIS; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CARBOXYLIC ACIDS; CORTICOSTERONE; CROTON OIL; DRUG EVALUATION; EAR DISEASES; EDEMA; ISOXAZOLES; MALE; ORGAN SIZE; PREDNISOLONE; PRODRUGS; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033144772     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976363     Document Type: Article

References (47)

1. Albert, A., Chemical aspects of selective toxicity. Nature, 182, 421-423 (1958).
2. Al-Habet, S. M. H. and Lee, H. J., In vitro hydrolysis of steroid acid ester derivatives of prednisolone in plasma of different species. J. Pharm. Sci., 79, 916-918 (1990).
3. Avery, M. A. and Woolfrey, J. R., Antiinflammatory steroids: Wolfe, M. E. (Ed). Medicinal Chemistry and Drug Discovery, John Wiley & Sons, Inc., pp. 281-376 (1997).
4. Bird, J., Lay, J. C. and Lee, H. J., The effects of new local anti-inflammatory steroids on leucocyte migration and prostanoid liberation in rats. J. Pharm. Pharmacol., 38, 589-594 (1986a).
5. Bird, J., Kim, H. P. and Lee, H. J., Topical anti-inflammatory activity of esters of steroid-21-oic acids. Steroids, 47, 35-45 (1986).
6. Blackwell, G. J., Specificity and inhibition of glucocorticoid-induced macrocortin secretion from rat peritoneal macrophages. Br. J. Pharmacol., 79, 587-594 (1983).
7. Bodor, N., Harget, A. J. and Philip, E. W., Structure-activity relationships in the antiinflammatory steroids: A pattern-recognition approach. J. Med. Chem., 26, 318-328 (1983).
8. Bush, I. E., Chemical and biological factors in the activity of adrenocortical steroids. Pharmacol. Rev., 14, 374-392 (1962).
9. Criscuolo, D., Fraioli, F. and Bonifacio, V., Effects of a new glucocorticoid, deflazacort on pituitary-adrenal function in man: a comparison with prednisolone. Int. J. Clin. Pharmacol. Ther. Toxicol., 18, 37-41 (1980).
10. Elks, J., Steroid structure and steroid activity. Br. J. Dermatol., 94, 2-13 (1976).
11. 2 inhibitor which prevents prostaglandin generation. Nature, 278, 456-459 (1979).
12. Green, M. J. and Lutsky, B. N., Anti-inflammatory steroids: In handbook of Cardiovascular and anti-inflammatory agents, Verderame, M. (Ed), Boca Raton, Florida, 1986.
13. Heiman, A. S., Kim, H. P., Taraporewala, I. B. and Lee, H. J., A novel class of local anti-inflammatory steroids. 2nd communication, Arzneim.-Forsch./Drug Res., 39, 362-267 (1989).
14. Heiman, A. S., Taraporewala, I. B., McLean, H. M., Hong, D. and Lee, H. J., New potent topical anti-inflammatory steroids with reduced side effects: derivatives of steroid-16-carboxy esters. J. Pharm. Sci., 79, 617-621 (1990).
15. Heiman, A. S., Ko, D.-H., Chen, M. and Lee, H. J., New steroidal anti-inflammatory antedrug, Steroids, 62, 491-499 (1997).
16. Heiman, A. S., Hickman, F., Ko, D.-H. and Lee, H. J., New steroidal anti-inflammatory antedrugs bind to macrophage glucocorticoid receptors and inhibit nitric oxide generation. Steroids, 63, 644-649 (1998).
17. Hench, P. S., Kendall, E. C., Slocumb, C. H. and Polley, H. F., Proceedings of the Staff Meetings of the Mayo Clinic. Arch. Int. Med., 85, 545-666 (1950).
18. Khalil, M. A., Lay, J. C. and Lee, H. J., Synthesis of a new anti-inflammatory steroidal acid ester: methyl 11β-hydroxy-3,20-dioxo-1,4-pregnadien-21-oate. J. Pharm. Sci., 74, 180-183 (1985).
19. Khalil, M. A., Maponya, M. F., Ko, D.-H., You, Z. and Lee, H. J., New antiinflammatory steroids: [17α,16α-d]-isoxazoline derivatives of prednisolone and 9α-fluoroprednisolone. J. Med. Chem. Res. 6, 52-60 (1996).
20. Kimura, T, Yamaguchi, T., Usuki, K., Kurosaki, Y., Nakayama, T., Fujiwara, Y., Matsuda, Y., Unno, K. and Suzuki, T., Colonic mucosa-specific pro-antedrugs for oral treatment of ulcerative colitis: design, synthesis and fate of methyl 20-glucopyranosyloxyprednisolonates. J. Control. Release, 30, 125-135 (1994).
21. Ko, D.-H., Maponya, M. F., Khalil, M.A., You, Z. and Lee, H. J., New anti-inflammatory steroids: [17α,16α-d]-3′-hydroxy-iminoformylisoxazoline derivatives of prednisolone and 9α-fluoroprednisolone. J. Med. Chem. Res. 7, 313-323 (1997).
22. Kumari, D. and Lee, H. J., Hydrolysis of methyl steroid 21-oates and acetyl steroid 21-ols by rat liver microsomes. Drug Metab. Desp., 13, 627-629 (1985).
23. Kwon, T., Heiman, A. S., Oriaku, E. T., Yoon, K. and Lee, H. J., New steroidal antiinflammatory antedrugs: steroidal [17α,16α-d]-3′-carethoxyisoxazolines. J. Med. Chem., 38, 1048-1051 (1995).
24. Laurent, H., Gerhards, E. and Weichert, R., Synthesis of novel anti-inflammatory steroids. Angew. Chem. Int. Ed. Engl., 14, 65-69 (1975).
25. Lee, H. J. and Soliman, M. R. I., Anti-inflammatory steroids without pituitary adrenal suppression. Science, 215, 989-991 (1982).
26. Lee, H. J., Khalil, M. A. and Lee, J. W., Antedrug: A conceptual basis for safer antiinflammatory steroids. Drugs Expl. Clin. Res., 10, 835-844 (1984).
27. Lee, J. W. and Lee, H. J., Binding of ester and amide epimers of 20-dihydro-prednisolonic acid to cytosol receptors and their acute pharmacological activities in rats. J. Steroid. Biochem., 23, 943-948 (1985).
28. Lee, H. J., Heiman, A. S. and Taraporewala, B., New steroidal anti-inflammatory drugs: Rainsford, K.D. & Velo, G. P. (Eds.). New developments in antirheumatic therapy, vol. III. pp. 153-186 (1989).
29. Lee, H. J., You, Z., Ko, D.-H. and McLean, H. M., Recent advances in prodrugs and antedrugs. Curr. Opinion in Drug Discov. Dev. September vol. 1, No. 2, 235-244 (1998a).
30. Lee, H. J., You, Z., Ko, D.-H. and Yoon, K. J., New steroidal antiinflammatory agents: prednisolone derivatives with a isoxazoline fusion at the 16- and 17-carbons and an alkyl carbonylate at the 16α-position. Drug Exptl. Clin. Res., 24 (2), 57-66 (1998b).
31. Lewbart, M. L. and Mattox, V. R., Conversion of steroid-17-yl glyoxals to epimeric glycolic esters. J. Org. Chem., 28, 1779-1786 (1963).
32. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
33. Monder, C., Synthesis of steroids containing the α-keto acid sidechain. Steroids, 18, 187-194 (1971).
34. Nijkamp, F. P., Flower, R. J., Moncado, S. and Vane, J. R., Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids, Nature, 263, 479-482 (1976).
35. Olejniczak, E. and Lee, H. J., Systemic effects of chronically administered methyl prednisolonate and methyl 17-deoxyprednisolonate. Steroids, 43, 657-662, (1984).
36. Phillips, G. H., Locally active corticoids: structure activity relationships. In Wilson, L. and Marks, R. (Eds.). Mechanism of topical coticoid activity. Livingstone, Edingburgh, U.K., pp. 1-18, 1976.
37. Phillips, G. H., Mechanism of topical corticosteroid activity. Glaxo symposium, London, 1976.
38. Ponec, M., Kempenaar, J. A. and Kloet, E. R., Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy. J. Invest. Dermatol., 76, 211-214 (1981).
39. Popper, T. L. and Watnick, A. S., Anti-inflammatory steroid: Scherer, R. A. and Whitehouse, M. W. (Eds.). Anti-i nflammatory Agents-Chemistry and Pharmacology, vol. 1, pp. 245-294 (1974).
40. Schlagel, C.A., Comparative efficacy of topical anti-inflammatory corticosteroids. J. Pharm. Sci., 54, 335-354 (1965).
41. Shroot, B., Caron, J. C. and Ponec, M., Glucocorticoid-specific binding: Structure-activity relationship. Br. J. Dermatol., 107 (suppl 23), 30-34 (1982).
42. Soliman, M. R. I. and Lee, H. J., Local antiinflammatory activity of acid ester derivatives of prednisolone. Res. Commun. Pathol. Pharmacol., 33, 357-360 (1981).
43. Taraporewala, I. B., Kim, H. B., Heiman, A. S. and Lee, H. J., A novel class of local anti-inflammatory steroids. 1st communication, Arzneim.-Forsch. / Drug Res., 39, 21-25 (1989).
44. Thalen, A. and Brattsand, E., Synthesis and anti-inflammatory properties of Budesonide, a new non-halogenated glucocorticoid with high local activity. Arzneim-Forsch Drug Res., 29 (II), 687-690 (1979).
45. Tonneli, G., Thiabault, L. and Ringler, J., A bioassay for the concomitant assessment of the antiphlogistic and thymolytic activities of topically applied corticosteroid. Endocrinol., 77, 625-634 (1965).
46. You, Z., Khalil, M. A., Ko, D.-H. and Lee, H. J., Suppression of the Mattox rearrangement of 16α-cyanoprednisolones in acid: synthesis of methyl 16α-prednisolonecarboxylates. Tetrahedron Lett., 36(19), 3303-3306 (1995).
47. You, Z. and Lee, H. J., One step conversion of highly dipolarophilic olefins to α-hydroxy-β-cyanoadducts with metal fulminate. Tetrahedron Lett., 37(8), 1165-1168 (1996).